ArticleSLAS discovery : advancing life sciences R & D2025

Combinatorial screen of targeted agents with the PI3K inhibitors inavolisib, alpelisib, duvelisib, and copanlisib in multi-cell type tumor spheroids.

Thomas S Dexheimer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.